BioQentix AI Private Limited Leadership
Sarvesh Goel, CEO
Senior analytical expert with 26+ years of experience in pharmaceutical drug development and quality analysis. Proven leader in formulation-integrated analytical development, specializing in method development, impurity profiling, and advanced characterization techniques. Experienced in managing high-end analytical laboratories and driving end-to-end product lifecycle—from API evaluation to commercialization. Strong track record in global regulatory compliance, successfully supporting USFDA, TGA, MHRA, and CDSCO audits while ensuring efficient and high-quality QC operations.
Dr.D.P. SRIVASTAVA, CSO
Senior Drug Discovery & Multi-Agentic AI Expert with 25+ years of experience in pharma and biotech R&D. Specialized in DMPK, ADME/PK-PD, clinical pharmacology, and AI-driven drug discovery platforms, with leadership experience at Daiichi-Sankyo, Zydus, Torrent, and Dolphin Labs. Expert in pharmacokinetics, metabolite analysis, bioavailability, and regulatory-compliant analytical methods, with strong knowledge of US FDA, ICH, EMA, and WHO standards. Ph.D.-qualified professional with a proven track record in building GLP-compliant labs and advancing NCE development in oncology and antibacterial therapies.